STELLA CHEMIFA to Develop PET System for Diagnosing Lifestyle-related Diseases.Tokyo, Japan, May 23, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - STELLA CHEMIFA announced on May 22 that it has undertaken a project to develop a positron-emission tomography (PET) system for diagnosing lifestyle-related diseases such as cerebrovascular cer·e·bro·vas·cu·lar adj. Relating to the blood supply to the brain, particularly with reference to pathological changes. cerebrovascular pertaining to the blood vessels of the cerebrum or brain. and cardiovascular diseases. The new system, which will use as imaging agents not only fluorodeoxyglucose (FDG FDG Fluorodeoxyglucose FDG Fundação de Desenvolvimento Gerencial FDG Franchise Development Group FDG Function Dependence Graph FDG Fraud Detection Group FDG Functional Dependency Gate FDG Front des Gaulois FDG Falling Down Giggling ) but also water, oxygen, carbon dioxide carbon dioxide, chemical compound, CO2, a colorless, odorless, tasteless gas that is about one and one-half times as dense as air under ordinary conditions of temperature and pressure. and carbon monoxide, can observe the blood flow and oxygen consumption of the brain and heart on a real-time basis. Accordingly, it will help detect an early sign of arteriosclerosis arteriosclerosis (ärtĭr'ēōsklərō`sis), general term for a condition characterized by thickening, hardening, and loss of elasticity of the walls of the blood vessels. , which results from metabolic syndrome. Going forward, STELLA CHEMIFA will carry out the project with Kobe-based bio venture company Molecular Imaging Lab and the National Cardiovascular Center. The three partners plan to commercialize the system and obtain approval from the Ministry of Health, Labor and Welfare in three years, aiming to generate sales of about 5 billion yen ($45.0 mil) in five years after receiving approval. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion